英菲格拉替尼2021年最新价格

Infigratinib (Truseltiq) is a small molecule ATP-competitive tyrosine kinase inhibitor of FGFR. Alterations of FGFR in tumors can lead to constitutive FGFR signaling that supports the proliferation and survival of malignant cells. Infigratinib (Truseltiq) blocks downstream signaling cascades by selectively binding to and inhibiting FGFR activity. Infigratinib (Truseltiq) induces tumor cell death by reducing cancer cell proliferation. Infigratinib (Truseltiq) is indicated for adult patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma and fibroblast growth factor receptor 2 (FGFR2) fusions or other rearrangements with an FDA-approved test. On May 28, 2021, the U.S. Food and Drug Administration accelerated its approval of infigratinib (Truseltiq). What is the latest price in 2021?

Infigratinib (Truseltiq) is not currently on the market in China, so the domestic price of the drug cannot be provided. Patients can purchase the cost-effective Infigratinib that is available overseas. The price of Infigratinib is not fixed due to exchange rate fluctuations and other factors. If patients want to know the latest price of Infigratinib that is available overseas in 2021, they can consult domestic professional overseas medical service companies (such as Medical Companion Travel). Patients can also obtain cost-effective Infigratinib (Truseltiq) through overseas medical service organizations such as Medical Travel, which not only saves them the trouble of going abroad, but also guarantees the purchase of genuine drugs, which is very convenient and fast.

Infigratinib usage and dosage

Infigratinib (Truseltiq) is administered orally at 125 mg daily for 21 days, followed by 7 days off, in 28-day cycles, until disease progression or unacceptable toxicity. Patients should strictly follow the doctor's instructions during treatment with Infigratinib (Truseltiq), and should not increase or decrease the dosage of Infigratinib (Truseltiq) without authorization to avoid adverse reactions caused by increasing or decreasing the dosage.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended hot articles: